Wallroth Donald E.

CIK 00014107091 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001410709

Recent Transactions

18 trades

Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-09-28−13,500→ 0 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-09-28$3.93/sh+13,500→ 37,500 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-09-25−4,000→ 0 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-09-25$3.93/sh+4,000→ 24,000 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-09-24−4,000→ 0 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-09-24$3.93/sh+4,000→ 20,000 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-09-23−4,000→ 0 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-09-23$3.93/sh+4,000→ 16,000 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-09-22$3.93/sh+4,000→ 12,000 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-09-22−4,000→ 0 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-09-18−8,000→ 0 total
Exercise/Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-09-18$3.93/sh+8,000→ 8,000 total
Disposition to Issuer
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-08-22−13,500→ 0 total
Sale
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-05-22$3.80/sh−4,000→ 16,000 total
Sale
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-05-22$3.75/sh−2,500→ 13,500 total
Award
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-05-12+90,000→ 90,000 total
Award
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-05-12+30,000→ 30,000 total
Award
Molecular Insight Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2009-05-12+60,000→ 60,000 total

Companies

Molecular Insight Pharmaceuticals, Inc.
Chief Financial Officer

Recent Filings

Address

MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET

CAMBRIDGE, MA, 02142

View on SEC.gov